This article is more than 5 years old. Information may no longer be current.

Quantel launches LacryDiag dry eye diagnosis device

Issue: June 2018

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

At the World Ophthalmology Congress in Barcelona, Spain, Quantel Medical launched the LacryDiag ocular surface analyzer for the diagnosis of dry eye.

Approved by the FDA and CE marked, the device analyzes the three tear film layers with four non-contact exams, according to a company press release.

“Dry eye is a real public health problem, but the symptoms are often misunderstood. As a multifactorial pathology that results from damage to the tear film, this pathology is often underdiagnosed and underestimated,” Jean-Marc Gendre, CEO of Quantel Medical, said in the release. “With LacryDiag, ophthalmologists are now able to diagnosis in a few minutes the three tear film layers to select a personalized treatment for the patient.”